mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |